Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » FDA Issues New Guidance on SARS-CoV-2 Variants for Test Developers

FDA Issues New Guidance on SARS-CoV-2 Variants for Test Developers

Feb 22, 2021
|
staff reporter

NEW YORK – The US Food and Drug Administration on Monday issued new guidance for SARS-CoV-2 test developers to evaluate the potential impact of viral mutations on the tests.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

A Few, as Expected

The US Centers for Disease Control and Prevention has identified a small group of breakthrough COVID-19 cases, the Wall Street Journal reports.

For the Unknown Soldiers

The New York Times reports that the US Department of Defense is to use genetic genealogy approaches to identify the remains of unknown soldiers.

Prep for the Next One

Vox and Nature discuss the importance of preparing for the next pandemic.

Nature Papers Compare CtDNA Assays, Examine Lettuce Domestication, More

In Nature this week: comparison of five circulating tumor DNA assays, resequencing analysis of lettuce gives insight into its domestication, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

  2. Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

  3. PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.